Inhibition of caspase activity with a pan-caspase inhibitor, as confirmed by caspase-3 assay (Figure 6A), did not significantly alter SHetA2 cytotoxicity, suggesting that SHetA2 works independently of caspase activity in cervical cancer cell lines (Figure 6B). Here, CASP3 is linked to cervical cancer.